🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Vegetarian Capsule(s) Serving Size
60 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 380.0mg (120 products) 📚 8 studies — no high-quality reviews
This product: 250mg
100 mg
📊 Market median: 380.0mg (120 products) 📚 8 studies — no high-quality reviews
This product: 100mg

Other Ingredients

Cellulose Vegetable Stearate

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (67% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Usage: As a dietary supplement, adults take 1 capsule daily between meals or as advised by your healthcare professional. If digestive irritation occurs, take with meals.

⚠️ Warnings & Precautions

Note: If pregnant or nursing, consult your health care professional before using this product.

KEEP OUT OF REACH OF CHILDREN.

Tamper resistant package, do not use if outer seal is missing.

Stop use and consult your health care professional if allergic reactions occur.

🧪 Formulation Notes

Feverfew (Tanacetum parthenium [L.] Schultz-Bip.) contains bitter-tasting sesquiterpene lactones (parthenolide, michefuscalide, chrysanthenyl acetate, chrysanthemonin, chrysartemin A and B, and santamarin), tannins, betafarnesene and camphor. This extract is standardized at 0.2% total sesquiterpenes, expressed as parthenolide.

Standardized Herbal Extract Supplement 0.2% parthenolide (sesquiterpenes)

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)

Formula #77324

Product Details

UPC / SKU 3 10539 67324 9
DSLD Entry Date 2012-06-01
Product Type Botanical
Form Capsule
DSLD ID 9624
Data Updated 2026-04-11

Research Evidence

10 Research Sources
48 Avg Quality Score
4 Systematic Review
4 Rct
1 Meta Analysis
1 Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985
View all evidence for Feverfew →

Compare Similar Products

View all Feverfew products →